Eledon Pharmaceuticals
(NASDAQ) ELDN
Eledon Pharmaceuticals Financials at a Glance
Market Cap
$216.24M
Revenue (TTM)
$0.00
Net Income (TTM)
$45.62M
EPS (TTM)
$-0.59
P/E Ratio
-4.85
Dividend
$0.00
Beta (Volatility)
0.77 (Low)
Dividend
$0.00
Beta (Volatility)
0.77 (Low)
Price
$2.88
Volume
46,978
Open
$2.92
Price
$2.88
Volume
46,978
Open
$2.92
Previous Close
$2.88
Daily Range
$2.88 - $3.10
52-Week Range
$1.35 - $4.60
Dividend
$0.00
Beta (Volatility)
0.77 (Low)
Price
$2.88
Volume
46,978
Open
$2.92
Previous Close
$2.88
Daily Range
$2.88 - $3.10
52-Week Range
$1.35 - $4.60
ELDN News
ELDN: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Eledon Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
33
CEO
David-Alexandre C. Gros, MD, MBA
Website
eledon.comHeadquarters
Irvine, CA 92612, US
ELDN Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-36%
Return on Capital
-38%
Return on Assets
-19%
Earnings Yield
-20.62%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$216.24M
Shares Outstanding
75.08M
Volume
46.98K
Short Interest
0.00%
Avg. Volume
963.11K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$83.25M
EBITDA
$83.25M
Operating Cash Flow
$62.34M
Capital Expenditure
$0.00
Free Cash Flow
$62.34M
Cash & ST Invst.
$133.34M
Total Debt
$641.00K
Eledon Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
+100.0%
Gross Margin
0.00%
N/A
Market Cap
$216.24M
N/A
Market Cap/Employee
$6.98M
N/A
Employees
31
N/A
Net Income
$10.45M
+76.6%
EBITDA
$21.48M
+51.3%
Quarterly Fundamentals
Net Cash
$132.69M
-4.7%
Accounts Receivable
$514.00K
N/A
Inventory
$0.00
N/A
Long Term Debt
$283.00K
-55.8%
Short Term Debt
$358.00K
+14.0%
Return on Assets
-19.20%
N/A
Return on Invested Capital
-37.97%
N/A
Free Cash Flow
$14.09M
+25.8%
Operating Cash Flow
$14.09M
+25.8%